Archives of Science
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Arch Sci 7: 166,
  • DOI: 10.4172/science.1000166

Nuclear Medicine Approaches in the Management of Medullary Thyroid Carcinoma: An Updated Perspective

Wiam Elshami*
Department of Nuclear Medicine, Zonguldak Bulent Ecevit University of Medicine, Turkey
*Corresponding Author : Wiam Elshami, Department of Nuclear Medicine, Zonguldak Bulent Ecevit University of Medicine, Turkey, Email: Elshami446@gmail.com

Received Date: Jul 03, 2023 / Published Date: Jul 31, 2023

Abstract

Medullary thyroid carcinoma (MTC) is a rare form of thyroid cancer that requires a comprehensive management approach. Nuclear medicine plays a critical role in the diagnosis, staging, treatment, and follow-up of MTC. This article provides an updated perspective on the applications of nuclear medicine approaches in the management of MTC.Diagnostic techniques such as thyroid scintigraphy, positron emission tomography (PET), and molecular imaging with somatostatin receptor scintigraphy (SRS) aid in accurate diagnosis and staging of MTC, enabling appropriate treatment planning. Additionally, nuclear medicine techniques facilitate the measurement of biomarkers like calcitonin and carcinoembryonic antigen, aiding in prognostication and treatment response assessment. Targeted radionuclide therapy (TRT) has emerged as a promising treatment option, delivering localized radiation therapy to MTC cells usingradiolabeled compounds. Furthermore, nuclear medicine modalities contribute to post-treatment monitoring, detecting recurrence or metastases. Continued advancements in nuclear medicine imaging and targeted therapies hold great potential in improving the precision and effectiveness of MTC management. Collaboration between clinicians, nuclear medicine specialists, and researchers is essential for optimizing nuclear medicine’s role in MTC and enhancing patient outcomes in this complex malignancy.

Citation: Elshami W (2023) Nuclear Medicine Approaches in the Management ofMedullary Thyroid Carcinoma: An Updated Perspective. Arch Sci 7: 166. Doi: 10.4172/science.1000166

Copyright: © 2023 Elshami W. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top